Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

KalVista Pharmaceuticals is Profiled in this Database

Updated At 11 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME)

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of KalVista Pharmaceuticals plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About KalVista Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients